Free tool
Stocks far below their 52-week high
We cover 27 companies trading at least 50% below their own 52-week high. The median market value in the group is $32.03B. Across the group, the median move over the past trading day is −0.10%. 4% of the 26 with a 200-day average trade above it. Price change over the past year runs from −84.0% to −38.0% across the middle 80 percent of the group, with a median of −53.8%.
Other lists in this group
Table
27 of 4,095 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| GILD34.SA | Gilead Sciences, Inc. | 63.72 BRL | −81.50% | −81.40% | −79.11% |
| VRTX34.SA | Vertex Pharmaceuticals Incorporated | 88.56 BRL | +14.82% | −85.60% | −83.18% |
| MDTC34.SA | Medtronic plc | 59.52 BRL | +13.44% | −77.24% | −75.74% |
| M1CK34.SA | McKesson Corporation | 72.17 BRL | +2.08% | −93.69% | −92.49% |
| ESL.DE | EssilorLuxottica Société anonyme | 160.00 EUR | −2.85% | −38.15% | −39.11% |
| EL.PA | EssilorLuxottica Société anonyme | 159.15 EUR | −3.60% | −38.64% | −38.15% |
| C1IC34.SA | The Cigna Group | 59.58 BRL | −3.85% | −84.24% | −85.33% |
| B1SX34.SA | Boston Scientific Corporation | 62.21 BRL | +4.52% | −87.91% | −89.24% |
| BSX | Boston Scientific Corporation | $48.17 | +4.58% | −49.14% | −54.50% |
| BSX.DE | Boston Scientific Corporation | 42.30 EUR | +3.18% | −47.52% | −53.11% |
| A1GI34.SA | Agilent Technologies, Inc. | 72.26 BRL | +7.99% | −81.18% | −77.37% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $239.00 | −17.13% | −40.28% | −47.38% |
| ZOE.DE | Zoetis Inc. | 65.74 EUR | −4.92% | −38.01% | −49.47% |
| ZTS | Zoetis Inc. | $77.52 | +0.01% | −37.91% | −49.50% |
| Z1TS34.SA | Zoetis Inc. | 24.94 BRL | +0.56% | −40.91% | −52.31% |
| A1LN34.SA | Alnylam Pharmaceuticals, Inc. | 62.25 BRL | −15.31% | −44.14% | −49.35% |
| SMMT | Summit Therapeutics Inc. | $14.23 | +13.39% | −18.78% | −42.63% |
| AFW.DE | Align Technology, Inc. | 143.00 EUR | −6.14% | +7.68% | −54.37% |
| I1QV34.SA | IQVIA Holdings Inc. | 84.64 BRL | −67.80% | −72.39% | −67.19% |
| PODD | Insulet Corporation | $143.38 | −14.38% | −49.32% | −57.12% |
| HIMS | Hims & Hers Health, Inc. | $29.83 | +1.74% | −10.72% | −32.22% |
| COH.AX | Cochlear Limited | 136.01 AUD | +11.03% | −47.23% | −53.79% |
| DOCS | Doximity, Inc. | $24.74 | +15.39% | −42.85% | −63.61% |
| 4506.T | Sumitomo Pharma Co., Ltd. | 1,436.50 JPY | +13.47% | −41.63% | −3.59% |
| RGC | Regencell Bioscience Holdings Limited | $5.50 | −7.87% | −73.22% | −61.38% |
| EBO.AX | EBOS Group Limited | 17.51 AUD | −7.26% | −23.87% | −37.83% |
| ADMA | ADMA Biologics, Inc. | $9.63 | +9.56% | −46.14% | −44.17% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.